Clinical trials: psoriasis
Psoriasis
Randomized Study of PH-10 for Psoriasis
PH-10 is an aqueous hydrogel formulation of rose bengal disodium (RB) for topical administration to the skin, and is being studied for the treatment of cutaneous skin disorders, specifically psoriasis and atopic dermatitis.
- Trial name
- NCT01247818
- Testing
- PH-10 (0.002% Rose Bengal), PH-10 (0.005% Rose Bengal), PH-10 (0.01% Rose Bengal)
- Where
- 4 sites in United States
- Volunteers
- 99 people
- Sponsor
- Provectus Pharmaceuticals
Psoriasis, Inflammatory Bowel Diseases
Shortening Treatments Of Chronic Inflammatory Conditions
Background Psoriasis is a common disease which is a source of major distress for patients and costs for the society. Treatments are effective but temporary and relapses occur, preferentially at sites previously involved.
- Trial name
- STOIC (NCT04848649)
- Testing
- Study arm
- Volunteers
- 60 people
- Sponsor
- Centre Hospitalier Universitaire de Besancon
Plaque Psoriasis
Study to Assess the Reliability of PASI Scoring Using Digital-Based Images
This is an open-labeled study to evaluate the reliability of digital photographs for the remote assessment of the disease severity of plaque psoriasis.
- Trial name
- NCT05835843
- Testing
- In-Person and Remote Disease Assessment
- Where
- Canada
- Volunteers
- 34 people
- Sponsor
- Innovaderm Research Inc.
Spondyloarthritis (SpA), Psoriatic Arthritis (PsA)
Assessment of Nutritional Status in Rheumatic Diseases and Association to Disease Activity
The aim of the present work is to assess the nutritional status among different rheumatic diseases patients and to study its association with the corresponding diseases activity.
- Conditions
- Spondyloarthritis (SpA), Psoriatic Arthritis (PsA), Systemic Lupus Erythematous (SLE), Systemic Sclerosis (SSc)
- Trial name
- NCT07277491
- Where
- Egypt
- Volunteers
- 460 people, healthy volunteers welcome
- Sponsor
- Cairo University
Psoriatic Arthritis
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
An open label phase 3 study
- Trial name
- NCT04991116
- Testing
- TILD sub-cutaneous (SC) injection
- Where
- 99 sites in United States, Australia and 12 more
- Volunteers
- 529 people
- Sponsor
- Sun Pharmaceutical Industries Limited
Psoriasis
Phase IV Clinical Study of Benvitimod Cream in the Treatment of Mild to Moderate Psoriasis in Adults
This is a multi-center, prospective post-approval clinical Phase IV study to evaluate the safety and efficacy of Benvitimod cream, 1% twice daily for the treatment of mild to moderate stable psoriasis vulgaris in adults.
- Trial name
- NCT05064748
- Testing
- Benvitimod
- Where
- China
- Volunteers
- 2,000 people
- Sponsor
- Peking University People's Hospital
Psoriasis
Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis
Our laboratory is studying a skin disease known as psoriasis. The purpose of this protocol is to study the action and the effects of Efalizumab, on psoriasis.
- Trial name
- NCT00115076
- Testing
- Efalizumab
- Where
- 2 sites in United States
- Volunteers
- 31 people
- Sponsor
- Rockefeller University
Psoriasis, Depressive Symptoms
Smart Phone Delivered Cognitive Behavioral Therapy for Adults With Psoriasis and Co-Morbid Depression Symptoms
A single arm, pilot study in which all eligible participants will be enrolled in an 8-week coach-guided smartphone delivered CBT program. The full duration of the program, with follow-up interview, will be 9 weeks.
- Trial name
- NCT06216691
- Testing
- Coach-guided smartphone delivered CBT program.
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Brigham and Women's Hospital
Actively Extending Plaque Psoriasis, Moderate to Severe Plaque Psoriasis
Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis
The purpose of this study is to evaluate different dose levels of IMO-3100 compared to placebo administered for 4 weeks to patients with moderate to severe plaque psoriasis.
- Trial name
- NCT01622348
- Testing
- IMO-3100 at 0.16 mg/kg, Saline for Injection, IMO-3100 at 0.32 mg/kg
- Where
- 13 sites in United States
- Volunteers
- 44 people
- Sponsor
- Idera Pharmaceuticals, Inc.
Psoriasis Vulgaris, Tuberculosis
Frequency of Tuberculosis in Psoriasis Patients
Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center.
- Trial name
- NCT06563635
- Where
- Turkey (Türkiye)
- Volunteers
- 719 people
- Sponsor
- Bezmialem Vakif University
Palmoplantar Psoriasis
Efficacy Study of TEPSO® Socks in Improving Palmoplantar Psoriasis
The purpose of this study is to evaluate the efficacy of a special sock, manufactured using TEPSO®, compared to a normal cotton sock in the prognosis of symmetrical palmoplantar psoriasis present for at least one year.
- Trial name
- NCT01197976
- Testing
- TEPSO cloth, Standard cloth
- Where
- 3 sites in Italy
- Volunteers
- 20 people
- Sponsor
- Lenzi Egisto S.P.A.
Rheumatoid Arthritis, Spondyloarthritis
Information and Acceptability of Biosimilars
Patients with rheumatoid arthritis or spondyloarthritis, currently treated or about to be started with anti-TNF original drug adalimumab or etanercept will be included and randomized to either " information leaflet only " or "…
- Conditions
- Rheumatoid Arthritis, Spondyloarthritis, Psoriatic Arthritis
- Trial name
- BIOSIMINFO (NCT04321291)
- Testing
- Generic information leaflet, Individual information by nurse on biosimilars
- Where
- France
- Volunteers
- 500 people
- Sponsor
- University Hospital, Montpellier
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
This is a study to compare the efficacy of bimekizumab versus secukinumab in subjects with moderate to severe chronic plaque psoriasis (PSO).
- Trial name
- BE RADIANT (NCT03536884)
- Testing
- Bimekizumab, Secukinumab
- Where
- 77 sites in United States, Australia and 9 more
- Volunteers
- 743 people
- Sponsor
- UCB Biopharma SRL
Plaque Psoriasis
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
The purpose of the study is to evaluate the efficacy of an oral tablet formulation of JNJ-77242113 compared with placebo in participants with moderate-to-severe plaque psoriasis.
- Trial name
- SUMMIT (NCT05357755)
- Testing
- JNJ-77242113
- Where
- 34 sites in United States, Canada and 4 more
- Volunteers
- 90 people
- Sponsor
- Janssen Research & Development, LLC
Psoriasis
An Efficacy Study of Secukinumab in Plaque Psoriasis Patients With Subclinical Psoriatic Arthritis as Measured by Musculoskeletal Ultrasound
Given the role of IL-17 in the development of entheseal-driven pathology, a therapeutic strategy aimed at blocking IL-17 would be a logical option for the treatment of subclinical enthesitis in psoriasis patients.
- Trial name
- INTERCEPT (NCT04488185)
- Testing
- Secukinumab 300 mg
- Sponsor
- Novartis Pharmaceuticals
Psoriasis, Pruritus
Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry Skin and Pruritus
The product RL3020-DP0364 developed by Pierre Fabre Laboratories moisturizes durably and repairs dry or atopic skin, especially in the case of certain dermatoses (atopic dermatitis, ichthyosis, etc ...) and erythema induced by…
- Conditions
- Psoriasis, Pruritus, Dry Skin
- Trial name
- NCT06800755
- Testing
- Dexeryl (RL3020-DP0364)
- Where
- Poland
- Volunteers
- 40 people
- Sponsor
- Pierre Fabre Dermo Cosmetique
Psoriasis
A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics
This is a multicenter, open-label study aim to evaluate the efficacy and safety of IBI112 in Chinese participants with plaque psoriasis who were treated with biologics and switched to IBI112.
- Trial name
- NCT05970978
- Testing
- regular treatment, Intensive treatment
- Where
- China
- Volunteers
- 152 people
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
Arthritis, Rheumatoid, Spondylarthropathies
Do Inflammatory Arthritis Inpatients Receiving Group Music Therapy Improve Pain Compared to Music Listening?
Pain management is rated by patients with inflammatory arthritis as the highest priority in their disease treatment. Past research showed that music therapy is associated with reduced pain and depression.
- Conditions
- Arthritis, Rheumatoid, Spondylarthropathies, Arthritis, Psoriatic, Inflammatory Arthritis
- Trial name
- NCT02436785
- Testing
- Music Therapy, Music Listening
- Where
- Canada
- Volunteers
- 13 people
- Sponsor
- University of British Columbia
Psoriasis
Clinical Assessment and Psychosocial Impact of Psoriasis
The purpose of this study is to explore the impact of plaque psoriasis on the different dimensions of patient life including psychological disorders, different types of addictions, and their consequences on health-related quality…
- Trial name
- EPIDEPSO (NCT01964443)
- Where
- 48 sites in Austria, Belgium and 10 more
- Volunteers
- 719 people
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
Psoriasis
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
The purpose of this study is to evaluate the efficacy and safety of guselkumab (CNTO 1959) in the treatment of participants with moderate to severe plaque-type psoriasis (scaly skin rash) who had inadequate response to…
- Trial name
- NAVIGATE (NCT02203032)
- Testing
- Ustekinumab, Guselkumab
- Where
- 85 sites in United States, Australia and 8 more
- Volunteers
- 872 people
- Sponsor
- Janssen Research & Development, LLC
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.